SCHEMBL7950890

SCHEMBL7950890

Cc1ccc2c(c1)N(CC(=O)c1ccco1)C(=O)C(N)CN2C(=O)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.38
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 3/20 0.35
TSHR P16473 2/20 0.35
ATM Q13315 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
USP2 O75604 1/20 0.33
DGKA P23743 1/20 0.33
MAPK1 P28482 1/20 0.33
RECQL P46063 1/20 0.33
HPGD P15428 1/20 0.33
APOBEC3A P31941 1/20 0.33
ESR2 Q92731 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
BRD4 O60885 1/20 0.33
KMT2A Q03164 1/20 0.33
AADAT Q8N5Z0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177943 0.86 TSHR (0.34) HTTALDH1A1KDM4ETSHRUSP2
SCHEMBL6176995 0.83 TSHR (0.40) ALDH1A1TSHRMAPK1RECQLAADAT
SCHEMBL6181983 0.83 CCKBR (0.36) HTTALDH1A1KDM4ESMN1; SMN2KMT2A
SCHEMBL6178413 0.81 ALDH1A1 (0.40) HTTALDH1A1TSHRSMN1; SMN2MAPK1
SCHEMBL7961449 0.81 HTT (0.43) HTTALDH1A1KDM4EPOLBTSHR
SCHEMBL6209886 0.80 TSHR (0.35) ALDH1A1TSHRAADAT
SCHEMBL6178664 0.78 CCKBR (0.52)
SCHEMBL6180213 0.77 TSHR (0.38) ALDH1A1TSHR
SCHEMBL6178953 0.77 CCKBR (0.47) KMT2A
SCHEMBL6178279 0.73 CYP3A4 (0.37) ALDH1A1TSHRL3MBTL1KMT2AAADAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed